XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional paid in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2022   349.4      
Beginning balance at Dec. 31, 2022 $ (309.4) $ 0.0 $ 2,511.6 $ (2,772.1) $ (48.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of restricted stock units and awards (in shares)   8.0      
Shares withheld related to net share settlement of restricted stock units and awards (in shares)   (2.9)      
Shares withheld related to net share settlement of restricted stock units and awards (66.2)   (26.1) (40.1)  
Repurchases of common stock (in shares)   (15.0)      
Repurchases of common stock (331.7)   (136.1) (195.6)  
Exercise of stock options and awards (in shares)   0.1      
Exercise of stock options and awards 1.2   1.2    
Stock-based compensation 171.3   171.3    
Other comprehensive income 10.7       10.7
Net income 112.2     112.2  
Ending balance (in shares) at Jun. 30, 2023   339.6      
Ending balance at Jun. 30, 2023 (411.9) $ 0.0 2,521.9 (2,895.6) (38.2)
Beginning balance (in shares) at Mar. 31, 2023   343.7      
Beginning balance at Mar. 31, 2023 (365.2) $ 0.0 2,501.6 (2,827.5) (39.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of restricted stock units and awards (in shares)   4.3      
Shares withheld related to net share settlement of restricted stock units and awards (in shares)   (1.5)      
Shares withheld related to net share settlement of restricted stock units and awards (32.1)   (13.2) (18.9)  
Repurchases of common stock (in shares)   (6.9)      
Repurchases of common stock (155.2)   (62.8) (92.4)  
Exercise of stock options and awards 1.0   1.0    
Stock-based compensation 95.3   95.3    
Other comprehensive income 1.1       1.1
Net income 43.2     43.2  
Ending balance (in shares) at Jun. 30, 2023   339.6      
Ending balance at Jun. 30, 2023 (411.9) $ 0.0 2,521.9 (2,895.6) (38.2)
Beginning balance (in shares) at Dec. 31, 2023   336.7      
Beginning balance at Dec. 31, 2023 $ (165.8) $ 0.0 2,598.0 (2,742.3) (21.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of restricted stock units and awards (in shares)   7.1      
Shares withheld related to net share settlement of restricted stock units and awards (in shares) (2.7) (2.7)      
Shares withheld related to net share settlement of restricted stock units and awards $ (76.0)   (26.7) (49.3)  
Repurchases of common stock (in shares)   (22.4)      
Repurchases of common stock (543.8)   (220.0) (323.8)  
Exercise of stock options and awards 0.1   0.1    
Stock-based compensation 168.5   168.5    
Other comprehensive income 2.9       2.9
Net income 242.8     242.8  
Ending balance (in shares) at Jun. 30, 2024   318.7      
Ending balance at Jun. 30, 2024 (371.3) $ 0.0 2,519.9 (2,872.6) (18.6)
Beginning balance (in shares) at Mar. 31, 2024   327.7      
Beginning balance at Mar. 31, 2024 (277.2) $ 0.0 2,554.8 (2,811.6) (20.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of restricted stock units and awards (in shares)   3.7      
Shares withheld related to net share settlement of restricted stock units and awards (in shares)   (1.4)      
Shares withheld related to net share settlement of restricted stock units and awards (34.7)   (14.2) (20.5)  
Repurchases of common stock (in shares)   (11.3)      
Repurchases of common stock (262.2)   (111.2) (151.0)  
Stock-based compensation 90.5   90.5    
Other comprehensive income 1.8       1.8
Net income 110.5     110.5  
Ending balance (in shares) at Jun. 30, 2024   318.7      
Ending balance at Jun. 30, 2024 $ (371.3) $ 0.0 $ 2,519.9 $ (2,872.6) $ (18.6)